Mambro A, Mortazhejri S, Ortiz-Paredes D, Patey A, Fontaine G, Dussault C
Viruses. 2025; 16(12.
PMID: 39772217
PMC: 11680397.
DOI: 10.3390/v16121910.
Emery H, Evans C, Jack K, Martello E, Seripenah P, Aiyelabegan F
J Viral Hepat. 2024; 32(2):e14049.
PMID: 39731473
PMC: 11681497.
DOI: 10.1111/jvh.14049.
Draper B, Yee W, Bowring A, Naing W, Kyi K, Htay H
BMC Health Serv Res. 2024; 24(1):80.
PMID: 38229074
PMC: 10792827.
DOI: 10.1186/s12913-023-10456-0.
Kronfli N, Dussault C, Bartlett S, Fuchs D, Kaita K, Harland K
Can Liver J. 2022; 4(3):292-310.
PMID: 35992251
PMC: 9202774.
DOI: 10.3138/canlivj-2020-0035.
Wurcel A, Reyes J, Zubiago J, Koutoujian P, Burke D, Knox T
PLoS One. 2021; 16(5):e0250901.
PMID: 34038430
PMC: 8153419.
DOI: 10.1371/journal.pone.0250901.
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
Serumondo J, Penkunas M, Niyikora J, Ngwije A, Kiromera A, Musabeyezu E
BMC Public Health. 2020; 20(1):946.
PMID: 32546216
PMC: 7298738.
DOI: 10.1186/s12889-020-09000-0.
Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.
Crowley D, Cullen W, Lambert J, Van Hout M
PLoS One. 2019; 14(9):e0222186.
PMID: 31509571
PMC: 6738615.
DOI: 10.1371/journal.pone.0222186.
Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
Crowley D, Murtagh R, Cullen W, Keevans M, Laird E, McHugh T
Harm Reduct J. 2019; 16(1):42.
PMID: 31277665
PMC: 6612120.
DOI: 10.1186/s12954-019-0313-7.
Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.
Crowley D, Van Hout M, Murphy C, Kelly E, Lambert J, Cullen W
BMC Nurs. 2019; 18:23.
PMID: 31210751
PMC: 6567378.
DOI: 10.1186/s12912-019-0347-x.
Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: a rapid-realist review.
Francis-Graham S, Ekeke N, Nelson C, Lee T, Haj S, Rhodes T
BMC Health Serv Res. 2019; 19(1):152.
PMID: 30849986
PMC: 6408812.
DOI: 10.1186/s12913-019-3970-z.
Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.
Crowley D, Van Hout M, Murphy C, Kelly E, Lambert J, Cullen W
Health Justice. 2018; 6(1):23.
PMID: 30569249
PMC: 6755610.
DOI: 10.1186/s40352-018-0081-6.
Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.
Crowley D, Van Hout M, Lambert J, Kelly E, Murphy C, Cullen W
Harm Reduct J. 2018; 15(1):62.
PMID: 30538000
PMC: 6288965.
DOI: 10.1186/s12954-018-0269-z.
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area.
Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Vonk Noordegraaf-Schouten M
Epidemiol Rev. 2018; 40(1):105-120.
PMID: 29648594
PMC: 5982719.
DOI: 10.1093/epirev/mxy001.
Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study.
Goutzamanis S, Doyle J, Thompson A, Dietze P, Hellard M, Higgs P
BMC Infect Dis. 2018; 18(1):151.
PMID: 29609552
PMC: 5879642.
DOI: 10.1186/s12879-018-3057-1.
Acquiring hepatitis C in prison: the social organisation of injecting risk.
Treloar C, McCredie L, Lloyd A
Harm Reduct J. 2015; 12:10.
PMID: 25903401
PMC: 4413553.
DOI: 10.1186/s12954-015-0045-2.
Hepatitis C in European prisons: a call for an evidence-informed response.
Arain A, Robaeys G, Stover H
BMC Infect Dis. 2014; 14 Suppl 6:S17.
PMID: 25252822
PMC: 4178549.
DOI: 10.1186/1471-2334-14-S6-S17.
Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.
Cramp M, Rosenberg W, Ryder S, Blach S, Parkes J
BMC Gastroenterol. 2014; 14:137.
PMID: 25100159
PMC: 4128826.
DOI: 10.1186/1471-230X-14-137.
A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons.
Craine N, Whitaker R, Perrett S, Zou L, Hickman M, Lyons M
Eur J Public Health. 2014; 25(2):351-7.
PMID: 25061233
PMC: 4376964.
DOI: 10.1093/eurpub/cku096.
A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.
Yap L, Carruthers S, Thompson S, Cheng W, Jones J, Simpson P
PLoS One. 2014; 9(2):e87564.
PMID: 24586281
PMC: 3937313.
DOI: 10.1371/journal.pone.0087564.
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors.
Harris M, Rhodes T
Harm Reduct J. 2013; 10:7.
PMID: 23651646
PMC: 3686576.
DOI: 10.1186/1477-7517-10-7.